Main > A1. CORP. INDEX. Fn-Fz > Forest Laboratories Inc./P

---

This data is not available for free

Forest Laboratories Inc./P's subsections
1999. 08.16.1999. (Depression)
2001. 10.01.2001. (Cardiology)
2001. 10.01.2001. (Depression)
2001. 10.01.2001. (GastroEnterolog)
2002. 12.02.2002. (Depression)
2003. 05.05.2003. (Depression)
2006. 09.25.2006. Exec VP &
2008. 01.10.2008. (LawSuit IP..) >
2008. 02.05.2005. (Neurology)
2010. 06.08.2010. TransTech Pharma
2010. 12.06.2010. Gruenenthal>Pain
2010. 12.20.2010. Gruenenthal>CF
2011. 03.01.2011. Pneumo.>COPD>R
2011. 04.13.2011. Corp. Acq.
2012. 02.24.2012. Pneumo.>CF
2012. 03.07.2012. Pierre Fabre
2012. 06.01.2012. Nabriva Therap.
2012. 10.23.2012. BR Moksha8
2013. 01.17.2013. CV.>HyperTens
2013. 05.09.2013. CV.>ADHF
2013. 07.26. Neuro>MDD>Levo.
2013. 08.14. Pneumo.>COPD:A+F
2013. 09.24. USA Patents
2013. 11.07. Patent>Nebivolol
2013. 11.21. Neuro.>Cariprazine
2013. 12.02. Neuro.>Asenapine
2014. 01.27. $1.8B Note Pricing
2014. 01.31. Patent>NAMENDA XR®
2014. 02.03. Acq. Aptalis Completed
2014. 02.14. Neuro>AD
2014. 03.21. Neuro>MDD>Cari.
2014. 03.31. Neuro>BiPolar Dep.
2014. 04.28. Acq. Furiex Pharma.
2014. 07.01. Acq. By: Actavis
Forest Pharmaceuticals Inc. C2
Patents
Web-Site
Z - OK

Forest Laboratories Inc./P's products
This section has no products